Search by Drug Name or NDC
NDC 69639-0101-04 AKYNZEO 300; .5 mg/1; mg/1 Details
AKYNZEO 300; .5 mg/1; mg/1
AKYNZEO is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Helsinn Therapeutics (U.S.), Inc.. The primary component is NETUPITANT; PALONOSETRON.
MedlinePlus Drug Summary
The combination of netupitant and palonosetron is used to prevent nausea and vomiting caused by cancer chemotherapy. Netupitant is in a class of medications called neurokinin (NK1) antagonists. It works by blocking neurokinin, a natural substance in the brain that causes nausea and vomiting. Palonosetron is in a class of medications called 5-HT3 receptor antagonists. It works by blocking serotonin, a natural substance in the body that causes nausea and vomiting.
Related Packages: 69639-0101-04Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Netupitant and Palonosetron
Product Information
NDC | 69639-0101 |
---|---|
Product ID | 69639-101_3730c0de-198d-4359-8dbd-aaaf47814560 |
Associated GPIs | 50309902290120 |
GCN Sequence Number | 072935 |
GCN Sequence Number Description | netupitant/palonosetron HCl CAPSULE 300-0.5 MG ORAL |
HIC3 | H6J |
HIC3 Description | ANTIEMETIC/ANTIVERTIGO AGENTS |
GCN | 37239 |
HICL Sequence Number | 041467 |
HICL Sequence Number Description | NETUPITANT/PALONOSETRON HCL |
Brand/Generic | Brand |
Proprietary Name | AKYNZEO |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Netupitant and Palonosetron |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | CAPSULE |
Route | ORAL |
Active Ingredient Strength | 300; .5 |
Active Ingredient Units | mg/1; mg/1 |
Substance Name | NETUPITANT; PALONOSETRON |
Labeler Name | Helsinn Therapeutics (U.S.), Inc. |
Pharmaceutical Class | Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Neurokinin 1 Antagonists [MoA], P-Glycoprotein Inhibitors [MoA], Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC], Substance P/Neurokinin |
DEA Schedule | n/a |
Marketing Category | NDA |
Application Number | NDA205718 |
Listing Certified Through | 2024-12-31 |
Package
NDC 69639-0101-04 (69639010104)
NDC Package Code | 69639-101-04 |
---|---|
Billing NDC | 69639010104 |
Package | 2 BLISTER PACK in 1 CARTON (69639-101-04) / 2 CAPSULE in 1 BLISTER PACK |
Marketing Start Date | 2014-10-13 |
NDC Exclude Flag | N |
Pricing Information | N/A |